87467-002-01

Manufacturer
Gold Inti Trade Corporation | Longway Technology(Guangzhou) Co., Ltd.
Effective date
2026-07-28
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-07-31 05:10:06

Label at a glance#

ProductSKINTIFIC 3X ACID INTENSIVE ACNE TREATMENT
Active ingredientSALICYLIC ACID
Label structure7 sections

Indications and uses

• For the treatment of acne. • Helps prevent new acne blemishes from forming. • Clears up acne blemishes and allows skin to heal.

Dosage and administration

• Clean the skin thoroughly before applying this product • Cover the entire affected area with a thin layer one to three times daily • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor • If bother some dryness or peeling occurs, reduce application to once a day or every other day.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

SALICYLIC ACID 1.0%

Purpose

OTC - PURPOSE SECTION

Treatment of acne

Uses

INDICATIONS & USAGE SECTION

• For the treatment of acne.
• Helps prevent new acne blemishes from forming.
• Clears up acne blemishes and allows skin to heal.

Warnings

WARNINGS SECTION

•For external use only.

Stop use and ask a doctor

OTC - STOP USE SECTION

if skin irritation occurs or gets worse side effects occur. You may report side effects to FDA at 1-800-FDA-1088.

When using this product

OTC - WHEN USING SECTION

skin irritation and dryness more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. • Rinse right away with water if it gets in eyes.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

• Clean the skin thoroughly before applying this product
• Cover the entire affected area with a thin layer one to three times daily
• Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
• If bother some dryness or peeling occurs, reduce application to once a day or every other day.

Inactive ingredients

INACTIVE INGREDIENT SECTION

WATER, PROPANEDIOL, NIACINAMIDE, GLUCONOLACTONE, POLYACRYLATE CROSSPOLYMER-6, SODIUM HYDROXIDE, PHENOXYETHANOL, BETAINE, SODIUM DEXTRAN SULFATE, PEG-40 HYDROGENATED CASTOR OIL, ZINC PCA, SUCCINIC ACID, DISODIUM EDTA, ETHYLHEXYLGLYCERIN, O-CYMEN-5-OL, MENTHOL, BENZOPHENONE-4

87467-002-01

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

00020002

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-134897147692627GTIN-13: 4897147692627
EAN-13: 4897147692627
GTIN storage (14 digits): 04897147692627
SKT-453.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87467-00287467-002-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SKINTIFIC 3X ACID INTENSIVE ACNE TREATMENTSALICYLIC ACIDGold Inti Trade Corporation57a7c929-31f5-ef82-e063-6394a90ab9af2026-07-28WarningsExact identifier
ndc (package): 87467-002-01
ndc (product): 87467-002
ndc11 (package): 87467000201
spl id: 57a7c929-31f4-ef82-e063-6394a90ab9af
spl set id: 57a7c929-31f5-ef82-e063-6394a90ab9af

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.